AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹21,330 Cr | ₹19,653 Cr | ₹17,667 Cr | ₹15,510 Cr | ₹13,578 Cr |
What is the latest Total Non-Current Assets ratio of AUROBINDO PHARMA ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹21,330 Cr |
| Mar2024 | ₹19,653 Cr |
| Mar2023 | ₹17,667 Cr |
| Mar2022 | ₹15,510 Cr |
| Mar2021 | ₹13,578 Cr |
How is Total Non-Current Assets of AUROBINDO PHARMA Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹21,330 Cr | 8.53 | |
| Mar2024 | ₹19,653 Cr | 11.24 | |
| Mar2023 | ₹17,667 Cr | 13.90 | |
| Mar2022 | ₹15,510 Cr | 14.23 | |
| Mar2021 | ₹13,578 Cr | - | |
Compare Total Non-Current Assets of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹89,253.2 Cr | -2.2% | 10.3% | 35.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -2.2% |
10.3% |
35.3% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses